戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s the complexity and intensity of healthcare continues to accelerate this is an important gap in exis
2 y of free treatment and care in the UK, AIDS continues to account for the majority of deaths in HIV-p
3 assive quantities of diverse omics data that continue to accumulate rapidly.
4 ts for most ultra-short DNA sequences, while continuing to accurately describe the J-factors of longe
5 se disseminate late from primary tumors, but continue to acquire mutations, mostly accessing the same
6                        The mesoporous shells continued to act as regulators restricting the release o
7 atients, the companion diagnostic model will continue to adapt and evolve.
8 ms as though astrocytic and neuronal biology continue to advance in parallel to each other, to the de
9 cule metabolite profiling in complex systems continue to advance rapidly, along with prospects for on
10 on with underlying neurocognitive impairment continues to afflict almost 50% of infected individuals.
11 tial extent of MOSSFA following DWH and will continue to aid in the determination of advective transp
12 otherapy and ongoing randomised studies will continue to aim to optimise treatment for high-risk neur
13         APAP administration began at 0 h and continued to 'ALF', defined as INR >3.
14                                  Researchers continue to analyze the precise mechanisms by which infl
15                   The 2017 McDonald criteria continue to apply primarily to patients experiencing a t
16                   Synthetic molecular motors continue to attract great interest due to their ability
17              Ferroelectric domain walls have continued to attract widespread attention due to both th
18     Targeting mutant KRAS signaling pathways continues to attract attention as a therapeutic strategy
19 ize the judicious use of antibiotics need to continue to be a focus of public health strategies direc
20 bed appropriately to treat infections, there continue to be a large number of inappropriately prescri
21                Established infectious agents continue to be a major cause of human morbidity and mort
22 c hyperplasia and bladder outlet obstruction continue to be a serious health problem.
23 and Zika virus transmitted by Aedes aegypti, continue to be a threat to global health by causing majo
24 omplex data sets remain challenges that must continue to be addressed.
25                           They have been and continue to be attractive synthetic targets because of t
26 tion is that twice-daily radiotherapy should continue to be considered the standard of care in this s
27                        Surgery and radiation continue to be curative treatments for localized disease
28 of FtsZ filaments and their role in division continue to be debated.
29                            As new strategies continue to be developed, it is equally important to con
30 a of biological processes, and new functions continue to be discovered even for well-known modifying
31  signaling pathways involved in pathogenesis continue to be discovered.
32 chanistic aspects of Fe/S protein biogenesis continue to be elucidated by biochemical and ultrastruct
33                        Sun protection should continue to be emphasized in white, Asian, and Hispanic
34 ys may result in artefacts, these inhibitors continue to be employed, owing to the absence of robust
35 al health settings yet restrictive practices continue to be frequently used.
36 ineering studies to establish causality will continue to be frustrated by an inability of footprintin
37 e-negative breast cancer, current treatments continue to be limited and ineffective.
38            Perinatal mortality and morbidity continue to be major global health challenges strongly a
39                                        Women continue to be more likely to practice in academic cente
40                                   There will continue to be significant heterogeneity among transplan
41 reasingly valuable as global water resources continue to be stretched to their limits and communities
42 eria, approximately 40% of cellular proteins continue to be synthesized even at saturating concentrat
43 r proteins are resistant to host shutoff and continue to be synthesized.
44                 Synthetic cannabinoids (SCs) continue to be the largest group of new psychoactive sub
45    Our simulations suggest that drought will continue to be the largest threat to US rainfed maize pr
46         This survey revealed that skin tests continue to be the main diagnostic procedure and are use
47  in general, and CPC and BAK, in particular, continue to be used in personal health care, food, and p
48 w-density lipoprotein level, statin exposure continued to be associated with a reduction in OAG risk.
49                                Five patients continued to be followed up as of March 2017.
50 inal significance and approximately 75% that continued to be GWS in the transancestry analysis.
51                                     Benefits continued to be observed with longer-term treatment, and
52 on, institutional support, and collaborators continued to be positive influential factors.
53  of tacrolimus trough levels <5 ng/ml, which continued to be significant after adjustment for HLA-DR/
54                 Acute myeloid leukemia (AML) continues to be a challenging disease to treat, thus new
55      Acute graft-versus-host disease (aGVHD) continues to be a frequent and devastating complication
56                         Exposure to violence continues to be a growing epidemic, particularly among c
57 eviously unavailable shapes and compositions continues to be a key need and interest in nanotechnolog
58                Invasive pneumococcal disease continues to be a major cause of morbidity and mortality
59 nded DNA (dsDNA) without sequence-preference continues to be a major challenge.
60             The emergence of drug resistance continues to be a major hurdle towards improving patient
61 infant death, the mainstay of risk reduction continues to be a safe sleep environment, as most infant
62             Management of such complications continues to be a significant challenge.
63           The economic cleanup of wastewater continues to be an active area of research.
64 t atmosphere and the solar wind acceleration continues to be an outstanding problem in solar-astrophy
65              This abnormal lipid environment continues to be associated with devastating vascular com
66  findings into effective clinical strategies continues to be elusive.
67  recognized, their exact function in the CNS continues to be explored.
68 otein trans-activator of transcription (Tat) continues to be expressed in virally suppressed patients
69 veryday clinical practice, but the diagnosis continues to be made in patients with late-stage disease
70 arly influenza virus infection later in life continues to be observed.
71 ardiovascular health of postmenopausal women continues to be of public health interest.This report ev
72 the master chromatin remodeling factor MTA1, continues to be poorly understood.
73 ransactivator of Transcription (Tat) protein continues to be present despite antiretroviral therapy a
74  plate cultures inoculated from swab samples continues to be the standard practice in clinical care.
75 lity of radiation dose according to facility continues to be wide.
76                            Provision of care continues to be worst in regions with the greatest socio
77               Allergy and atopic asthma have continued to become more prevalent in modern society des
78                 As laser cooling experiments continue to bring massive mechanical systems to unpreced
79 error (reversible with spectacle correction) continue to cause most cases of blindness and moderate o
80 c interventions, resistant fungal infections continue to cause significant morbidity and mortality in
81                   Mycobacterium tuberculosis continues to cause devastating levels of mortality due t
82 lammatory responses to bacterial infections, continues to cause high morbidity and mortality worldwid
83               Seasonal human influenza virus continues to cause morbidity and mortality annually, and
84 , and surveillance, Mycoplasma gallisepticum continues to cause significant morbidity, mortality, and
85 ved a primary-site cCR to IC and 51 patients continued to cetuximab with IMRT 54 Gy.
86                               Organ shortage continues to challenge the field of transplantation.
87 scured over longer timescales as populations continue to change and adapt to the shared features of t
88 or hemophilia A and hemophilia B will likely continue to change clinical practice.
89 s stabilize in cortical association areas or continue to change following learning.
90                      However, the field must continue to characterize the specific role pro-inflammat
91 ward the low intensity of the sated odor but continued to choose the high intensity of the nonsated o
92 thogenic avian influenza (HPAI) H5N1 viruses continue to circulate in nature and threaten public heal
93  or more diabetes-related autoantibodies and continue to contribute to type 1 diabetes (T1D) risk amo
94 ids, instead of arresting in G1, these cells continue to cycle and utilize lipid droplets as a source
95 t decrease significantly after the tear, but continued to decline compared with control eyes at all e
96 avenous chemotherapy agents had overuse that continued to decrease 6 months after the CW.
97 overage for polio, measles, and yellow fever continued to decrease, whereas the trend in coverage for
98            Advances in sequencing technology continue to deliver increasingly large molecular sequenc
99 y gold mining and agricultural companies but continue to depend on forests for house construction mat
100 e and SCD animals during infection, SCD mice continued to deteriorate and failed to resolve the infec
101 be stretched to their limits and communities continue to develop in flood-prone areas.
102 ompliance with these effective drugs, and to continue to develop new drugs that do not cause these si
103                            Mass spectrometry continues to develop as a valuable tool in the analysis
104 plications of chalcogen-bonding interactions continues to develop, debate still surrounds the energet
105 ompletely, with the result that acidic brine continues to diffuse through the carbonated zone to form
106 lp to conceive, plan, and develop the study; continue to direct the day-to-day conduct of the study;
107 ever, the analysis also shows that the field continues to discover appreciable numbers of natural pro
108                 In contrast, NE-treated rats continued to display accurate memory of the shock-contex
109  in industrial automation, and will probably continue to do so for decades to come.
110 orophyte dries from the outside inwardly and continues to do so after guard cells die and collapse.
111 le and aggregated brain amyloid-beta (Abeta) continues to dominate clinical research in AD, a deeper
112  which are histopathological hallmarks of AD-continues to drive significant drug research and develop
113      However, as a broad range of approaches continues to emerge, a universal framework is needed to
114 ures that health workers have been under and continue to endure, and the remarkable resilience and re
115 ted ERG in prostate cancer and other cancers continue to enhance its role in cancer biology and its u
116                                          MGD continues to enhance access to these data, to extend the
117 on currently underway or on the horizon will continue to evolve and expand the footprint of telemedic
118 passage indicates that influenza viruses can continue to evolve in galliform species, increasing thei
119 thogenic avian influenza (HPAI) H5N1 viruses continue to evolve in nature and threaten human health.
120               The shapes of the nanocrystals continue to evolve in terms of the intimate association
121 Finally a perspective on how this field will continue to evolve is provided.
122             As technologies for metabolomics continue to evolve, the depth and breadth of small-molec
123 lity as donation and transplantation systems continue to evolve.
124 gely unchanged, understanding of the disease continues to evolve.
125                                        As we continue to examine the mechanisms by which miRNAs maint
126 he rate of entry into pediatric surgery will continue to exceed population growth through 2030 under
127 tered to half the patients, and all patients continued to exercise for 2 minutes at the same workload
128 nents that are no longer necessary but might continue to exert their effects on recipient cells.
129 opment of endocrine resistance, ER signaling continues to exert a pivotal role in tumor progression i
130           However, only double-knockout mice continued to exhibit low liver Hamp at 8 weeks and faile
131 81 participants (29.5%; 95% CI, 25.9%-33.1%) continued to exhibit no clinical or laboratory evidence
132 alone under illumination by white light, and continued to exhibit superior catalytic properties follo
133 tients with severe renal insufficiency, will continue to expand options for cure even in these most d
134 ght technological developments in 2D IR that continue to expand the scope of scientific problems that
135 or a single "early burst" model, morphospace continued to expand following a slowdown in rates.
136                       As mobile phone access continues to expand globally, opportunities exist to lev
137              If the base-level Spillway Lake continues to expand to a fully formed moraine-dammed gla
138 nd the list of potential therapeutic targets continues to expand.
139 espite this progress, some population groups continue to experience an excessive cancer burden when c
140      Conclusion Ontario children with cancer continue to experience HI-EOL care.
141 e rendered completely seizure-free and 48.8% continued to experience postoperative seizure symptoms.
142  feeder visits became fixed early while bees continued to experiment with the order of later visits.
143                  Consistent with this, mTECs continue to express Fezf2 and Aire, regulators of intrat
144                                       MB NBs continue to express Imp into pupation, and the presence
145  in 2006 to 0.37% per year in 2016, and both continue to fall at a relative rate of 17% per year.
146 amics and the presence and abundance of mice continued to fluctuate with human mobility through the t
147                         Induction strategies continue to focus on increasing complete remission rates
148 nd address risk of malpractice claims should continue to focus on surgeons' ability to communicate re
149 bal market, yet most research and regulation continues to focus on a limited selection of rather well
150                  It is possible that RPE may continue to form a preserved photoreceptor-RPE complex t
151 pparent turnover frequency of 440 s(-1), and continue to generate additional initiators throughout th
152 s in chemical analysis and genome sequencing continue to greatly advance our understanding of this bi
153 rgeting events are disrupted, dopamine axons continue to grow ectopically from the nucleus accumbens
154 how, for the first time, that dopamine axons continue to grow from the striatum to the PFC during ado
155 ver, Rab35 compartments do not terminate and continue to grow into large elongated structures followi
156                            The crystals then continue to grow to develop morphologies characteristic
157                         Implantation volumes continue to grow, but several challenges remain to be ov
158 s the body of research concerning metastasis continues to grow at a rapid rate, the biological progra
159 n of causal effects using observational data continues to grow in popularity in the epidemiologic lit
160                                     Evidence continues to grow of the importance of in vitro and in v
161                        As the organ shortage continues to grow, the creation of social media communit
162 ealth threat on the rise, and its prevalence continues to grow.
163                     Poor delivery efficiency continues to hamper the effectiveness of cancer therapeu
164  with low input requirements, is expected to continue to have an important role in supplying food and
165                       However, many patients continue to have moderate-to-severe symptoms and are not
166 and eight years after MtBE was banned, 10.3% continue to have MtBE.
167                 However, HIV-positive blacks continue to have much higher rates of ESRD than HIV-posi
168   Many patients following a gluten-free diet continue to have symptoms and have small intestinal muco
169 he catastrophic loss of insulin, hep-tg mice continued to have significantly lower blood glucose.
170                           Animals in group 1 continued to have weight gain and biochemical analyses c
171                                    Influenza continues to have a substantial socioeconomic and health
172 s required in interpretation, structural MRI continues to have great promise in furthering our unders
173 chronic infections and malignant tumors will continue to help in the goal of optimizing immunotherapy
174 he lack of robust analytical techniques that continue to hinder the purification and characterization
175                                     Research continues to identify novel therapies, in particular eff
176 sable elements (TEs), whose ongoing activity continues to impact our genome.
177    Despite effective pharmacotherapy, asthma continues to impair quality of life for most patients.
178                             The HIV pandemic continues to impose enormous morbidity, mortality, and e
179        Short-term patient and graft outcomes continue to improve after kidney and liver transplantati
180 The National Institutes of Health (NIH) will continue to improve the Browser in response to user feed
181    New developments in cataract surgery will continue to improve the visual, anatomical, and patient-
182                     While interventions will continue to improve with the growth of developmental sci
183 ill likely increase as cancer survival rates continue to improve.
184  that short- and long-term clinical outcomes continue to improve.
185 nd 3) what are the arguments for and against continuing to include chronic disease endpoints in futur
186           Admissions for acute heart failure continue to increase but, to date, no new therapies have
187                               Drought events continue to increase in frequency and severity and ident
188 n the past several decades and are likely to continue to increase in the future under the influence o
189          Cardiovascular imaging technologies continue to increase in their capacity to capture and st
190 ses in (15)N enrichment in the shells, which continue to increase in value up to the modern shell val
191 quency and intensity of summer droughts will continue to increase.
192 -sensor retention at 6 hours (P = .003) that continued to increase at 24 hours after TAR (P = .0001).
193                      As thaw in Soil warming continued to increase linearly, ground surface subsidenc
194 cant health burden in western countries, and continues to increase in prevalence.
195 a being depositing into biological databases continues to increase, it becomes ever more vital to dev
196  use of nanopesticides in modern agriculture continues to increase, their effects on crop plants are
197 e model simulations.Antarctic sea ice extent continues to increase, with autumn sea ice advances in t
198  mortality, whereas the overall burden of HF continues to increase.
199 er stage of pathogenesis whereas amyloidosis continues to increase.
200 ldwide, with the prevalence of heart failure continuing to increase.
201 dividuals who previously experienced malaria continue to induce somatic hypermutations upon malaria r
202         Despite a large body of research, we continue to lack a detailed account of how auditory proc
203 in 3 Hispanic persons with a chronic disease continued to lack coverage and access to care after ACA
204   Variability in eye growth and myopic shift continue to make refractive outcomes challenging for IOL
205 em are not fully formed at birth, but rather continue to mature in response to the postnatal environm
206                           We showed that ASM continued to mature until approximately 3 wk after birth
207                 The ASRS ReST Committee will continue to monitor device-related and drug-related adve
208 sistance in An. funestus, it is necessary to continue to monitor the contribution of the mutations de
209                     Socioeconomic challenges continue to mount for half a billion residents of centra
210 ccur following initial binding to those that continue to occur days to weeks following infection.
211                            Measles outbreaks continue to occur in the United States and are mostly du
212 les vaccination campaigns, measles outbreaks continue to occur regularly in Nigeria, leading to high
213 ns in the years 2015-2016 but sporadic cases continued to occur.
214 hnological implications, as biosonar systems continue to outperform man-made sonar systems in noisy,
215                                              Continuing to overlook the vast majority of other PFASs
216                        Organ donor shortages continue to persist, especially in regions of the United
217 curity outside the contexts of official wars continues to plague many parts of the world.
218  morphology and clinical laboratory analysis continue to play an important role in defining these con
219  countries and around the world because they continue to pose major public health challenges.
220  along with other emerging influenza viruses continue to pose pandemic threats.
221  in low- and middle-income countries need to continue to prepare themselves to prevent additional hea
222                                       Sepsis continues to present a major burden to U.S. emergency de
223 olipids, by tandem mass spectrometry (MS/MS) continues to present a major challenge.
224                                       Rabies continues to present a public health threat in most coun
225 s such as insecurity and weak health systems continue to prevail in the poorest countries, inhibiting
226 numerous large anucleate viral vesicles that continue to produce virions.
227  remains unreceptive to embryo attachment by continuing to proliferate and failing to differentiate.
228                              The formed gaps continued to propagate after composite light curing fini
229 sis for a large number of genodermatoses and continue to provide a unique perspective on and insight
230 horts in diverse environments worldwide will continue to provide critical knowledge about the factors
231  into this interesting set of compounds will continue to provide insights into fundamental questions
232 Further exploration of the target genes will continue to provide new insights into the etiology of lu
233 on and next-generation sequencing approaches continue to provide promising new hints to answer these
234  to IEs were better maintained and these may continue to provide some protection.
235 ecent technical and theoretical developments continue to provide us with new insights.
236 terim analyses of KEYNOTE-006, pembrolizumab continued to provide superior overall survival versus ip
237 y removal and conventional immunosuppression continues to provide excellent patient and graft surviva
238    Development of vaccines for HIV infection continues to provide insight into the immune response ag
239 ERPRETATION: A single flexible sigmoidoscopy continues to provide substantial protection from colorec
240      Although long appreciated, this duality continues to puzzle immunologists and has implications f
241 ts with a proven indication for a PPI should continue to receive it in the lowest effective dose.
242          Among the remaining 49 patients, 16 continued to receive antibiotics, usually for infections
243 atients initially randomized to cyclosporine continued to receive cyclosporine-based immunosuppressio
244   After completion of chemotherapy, patients continued to receive rilotumumab or placebo monotherapy
245  alive; 27 (32%) and 11 (46%), respectively, continued to receive treatment.
246 of the either the mother or fetus, providers continue to recommend the women with HIV avoid pregnancy
247 g the UK, Canada, and Finland, however, have continued to recommend the use of the live vaccine.
248                            Disease outbreaks continue to reduce coral populations worldwide.
249 ndings and pose novel questions about how to continue to reduce the burdens of paediatric cancer.
250  to be developed, it is equally important to continue to refine our understanding and interpretation
251 iology for more than half a century and will continue to remain so, a major limitation of this techni
252                                          AMD continues to remain a significant public health problem
253 atients awaiting solid organ transplantation continues to remain much higher than the number of organ
254                                   Thus, dogs continue to represent an important reservoir for zoonoti
255 y contrast, complex congenital heart defects continue to require open-heart surgery.
256  link with FMRP loss >;25 years ago, studies continue to reveal diverse FMRP functions.
257 esults suggest that the alpine treeline will continue to rise, and that the alpine tundra may disappe
258 ore widespread relative to N as temperatures continue to rise.
259                     Incidence rates not only continued to rise over the 10-year period from 1998-2002
260 rbon concentrations declining as consumption continued to rise.
261                                       If CO2 continues to rise further into the twenty-third century,
262  the incidence and prevalence of the disease continues to rise globally.
263 , the total number of children with stunting continues to rise in sub-Saharan Africa.
264 al procedures performed in the United States continues to rise, and surgical patients are initially s
265 population worldwide, the incidence of falls continues to rise.
266 lions of people worldwide and its prevalence continues to rise.
267              Moreover, developmental biology continues to roll on, budding off more disciplines, whil
268 e experiments, of increasing scale and cost, continue to search for new particles and forces that mig
269                                        Flies continued to search around the original location, even a
270 he ongoing prevention trials, for which mAbs continue to serve as the mainstay.
271 thods evolve, these new systems of care must continue to serve the needs of children.
272 e goal of creating a more powerful tool that continues to serve the existing community while addressi
273  management, recognizing that more data will continue to shape best practices.
274     The chemotherapy plus bevacizumab groups continued to show significant improvement in OS compared
275  from clinical disease, while wild-type mice continued to show signs of disease.
276 rature [Formula: see text] or whether motion continues to slow gradually down to zero temperature.
277 y, our findings suggest that H10 viruses may continue to sporadically infect humans and other mammals
278 f Maine, white pine needle damage (WPND) has continued to spread and is now well established in all N
279 strumentation, and data processing platforms continue to spur growth in the lipidomics field, more st
280                      Anthropogenic pressures continue to squeeze available habitat and force animals
281 th exposure to repetitive brain trauma (RBT) continues to strengthen.
282 crobial resistance is essential if we are to continue to successfully treat infectious diseases.
283 morphologic assessment of hydatidiform moles continues to suffer from interobserver diagnostic variab
284 d age of onset for psychosis proneness; this continues to support the 22q11DS model as a valuable win
285                             Current evidence continues to support the benefits of an earlier rather t
286                                     Evidence continues to support the effectiveness of exercise, psyc
287                             Current evidence continues to support the use of selective serotonin reup
288 methodologies, a medicinal chemist's toolkit continues to swell.
289 plasmic fragments that lack genomic DNA, but continue to synthesize protein using a pool of messenger
290              Opportunistic fungal infections continue to take an unacceptably heavy toll on the most
291 eeding from NSAIDs should take a PPI if they continue to take NSAIDs.
292 dent, and thus plants without stomata should continue to take up COS in the dark.
293 d RT) core areas on the supratemporal plane, continuing to the rostrotemporal polar area (RTp) and ad
294 support for polio eradication activities and continue to this day by making financial contributions t
295            Emerging infectious diseases will continue to threaten public health and are sustained by
296 oms of withdrawal, many of these individuals continue to use opiates.
297 counting for these factors, the use of CRT-D continued to vary widely by hospital.
298 deteriorating under climate change as oceans continue to warm and acidify and thermal anomalies grow
299           "Home" intensivists were those who continued to work in their usual ICU; "visitor" intensiv
300 ximal and distal limb enhancers nevertheless continued to work independently over a targeted transgen

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top